HOME >> MEDICINE >> NEWS
Takeda responds to the FDA advisory committee recommendation

Deerfield, IL, July 30, 2007 Following a joint meeting today of the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development (TGRD) underscores its position that ACTOS ; (pioglitazone HCl) offers a proven safety profile regarding the risk of cardiovascular disease.

The breadth and depth of ACTOS data encompassing more than 16,000 patients over the past 10 yearsis consistent: Short- and long-term studies, both prospective and observational, studies in both humans and animals, all have shown no evidence that ACTOS is associated with an increased risk of heart attack or stroke, said Mehmood Khan, M.D., TGRD president. Critical in this body of data is the PROactive (PROspective PioglitAzone Clinical Trial In MacroVascular Events) study, since the only scientific way to determine a medications safety is a prospective, long-term trial.

About the PROactive Study

PROactive was a prospective, randomized, placebo-controlled outcomes trial. The PROactive study included 5,238 patients with type 2 diabetes and a history of macrovascular disease, who were force titrated up to 45 mg daily of either ACTOS or placebo. In this study, there was no difference in the number of macrovascular events between standard of care and ACTOS, and standard of care alone. Although there was no statistically significant difference between ACTOS and standard of care for the primary endpoint, there was no increase in mortality or total macrovascular events with ACTOS.

The ACTOS Prescribing Information was recently revised by the FDA to include this reassuring cardiovascular safety data. ACTOS is the only thiazolidinedione (TZD) with safety data from a cardiovascular outcomes trial in its label.

Although drugs may be in the same class, they also can have different clinical effects due to differences
'"/>

Contact: Cristina Sotolongo
Cristina.Sotolongo@ketchum.com
646-935-4021
Ketchum
30-Jul-2007


Page: 1 2

Related medicine news :

1. Takeda submits new drug application for extended-release type 2 diabetes medication, ACTOplus met
2. Takeda submits new drug application for combination type 2 diabetes medication
3. Stubborn ulcerative colitis responds to arthritis drug, review finds
4. American Egg Board responds to proposed USDA rule to revise WIC food package
5. Bradley Hospital responds to FDA report on ADHD drugs
6. Life-threatening lupus responds to stem cell transplant therapy
7. Pain research using electronic diaries helps identify who responds to placebo effect
8. Hepatitis C responds best to combo of ribavirin and interferon, study concludes
9. ARRS president responds to NAS report on ionizing radiation
10. Medical, IT, engineering experts form advisory panel for electronic health record safety
11. National Academies advisory: Native African vegetables

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/25/2019)... ... ... Auberge du Soleil , Napa Valley’s quintessential adult getaway, is partnering ... tea blend available exclusively for guests of the award-winning Auberge du Soleil Spa. Selected ... Auberge du Soleil + ERDA Spa Tea is now being served at the conclusion ...
(Date:3/25/2019)... Fla. (PRWEB) , ... March 25, 2019 , ... As ... treatments, Tampa, Fla.-based Physician Partners of America is adding a new specialist and pain ... spine procedures and interventional pain management at a new location: 9970 Central Park ...
(Date:3/23/2019)... (PRWEB) , ... March 23, 2019 , ... Highway West ... 2019. Health and nature enthusiasts will explore guided mindfulness and hiking in the blooming ... on Friday, April 19 by settling in and unwinding next to the Anza-Borrego Desert ...
(Date:3/23/2019)... ... 22, 2019 , ... Isagenix International , a global ... of business and transformed lives with the limited-edition Birthday Cake Flavor IsaLean® ... last, the meal replacement protein shake features sprinkles made with colors from natural ...
(Date:3/20/2019)... ... March 20, 2019 , ... Confluent Health is proud to ... owned outpatient physical and occupational therapy practice with seven locations in Baton Rouge, ... more than 55 years ago, our mission has been to deliver the highest ...
Breaking Medicine News(10 mins):
(Date:3/23/2019)... ... March 23, 2019 , ... Atkinson Ergonomic Solutions, Inc. ... of industry buzz. The Atkinson BedLift® allows a housekeeper to safely and single-handedly raise ... around a bed when it’s raised up and away from the wall are many. ...
(Date:3/20/2019)... FORT COLLINS, Colo. (PRWEB) , ... March 20, ... ... and green initiatives gather momentum across industries, the healthcare sector has woken up ... as plasticizers present in these products produce a range of toxic effects and ...
(Date:3/20/2019)... ... March 20, 2019 , ... 1888 Mills is announcing a ... protection technology – that will keep fabrics fresher and clean smelling longer. The ... through multiple brand offerings, such as the 1888 Mills’ new Freshee™ line, along ...
Breaking Medicine Technology:
Cached News: